Document is current
Any future updates will be listed below
-
Authors
Maspero, Elena https://orcid.org/0000-0001-6468-4796
Cappa, Anna
Weber, Janine
Trifirò, Paolo
Amici, Raffaella
Bruno, Agostino
Fagà, Giovanni https://orcid.org/0000-0002-7674-2583
Cecatiello, Valentina
Fattori, Raimondo
Leuzzi, Brian https://orcid.org/0000-0001-5237-2920
Taibi, Vincenzo
Meroni, Giuseppe
Pasi, Maurizio
Romussi, Alessia
Sartori, Luca
Villa, Manuela
Vultaggio, Stefania
Cirò, Marco
Soffientini, Paolo
Lombardo, Lierin https://orcid.org/0000-0002-8900-3560
Dahe, Shakti
Bachi, Angela
Varasi, Mario
Rossi, Mario
Pasqualato, Sebastiano https://orcid.org/0000-0002-9038-7768
Mercurio, Ciro https://orcid.org/0000-0001-6240-4607
Polo, Simona https://orcid.org/0000-0001-5536-9399
-
Funding
Funding for this research was provided by:
Worldwide Cancer Research (19-0003)
- License Information
-
More Information
Article History
Received: 23 January 2025
Accepted: 12 May 2025
First Online: 28 May 2025
Competing interests
: R.A., G.F., E.M., C.M., M.P., S.Pa., S.P., L.S. and M.Va. are patent co-inventors for “Hect E3 Ligase Nedd4 Inhibitors and uses thereof” (EP3976185B1). The remaining authors declare no competing interests.
